|
Volumn 354, Issue 18, 2006, Pages 1953-1954
|
Aprotinin in cardiac surgery [7]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINOCAPROIC ACID;
ANTICOAGULANT AGENT;
ANTIFIBRINOLYTIC AGENT;
APROTININ;
INOTROPIC AGENT;
TRANEXAMIC ACID;
SERINE PROTEINASE INHIBITOR;
AMINOCAPROIC ACID DERIVATIVE;
BLEEDING;
BLOOD TRANSFUSION;
CARDIOPULMONARY BYPASS;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
DRUG INDICATION;
EVIDENCE BASED PRACTICE;
HEART ATRIUM FIBRILLATION;
HEART INFARCTION;
HEART SURGERY;
HUMAN;
HYPOTENSION;
KIDNEY FAILURE;
LETTER;
META ANALYSIS;
PATIENT SELECTION;
PREOPERATIVE TREATMENT;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
STROKE;
SURGICAL MORTALITY;
SYSTEMATIC REVIEW;
METHODOLOGY;
NOTE;
POSTOPERATIVE HEMORRHAGE;
CONFLICT OF INTEREST;
EPIDEMIOLOGY;
WRITING;
CHEMICALLY INDUCED DISORDER;
DIABETES MELLITUS;
KIDNEY DISEASE;
RENAL REPLACEMENT THERAPY;
APROTININ;
CARDIAC SURGICAL PROCEDURES;
HUMANS;
POSTOPERATIVE HEMORRHAGE;
RESEARCH DESIGN;
SERINE PROTEINASE INHIBITORS;
AUTHORSHIP;
CAUSALITY;
CONFLICT OF INTEREST;
DIABETES COMPLICATIONS;
KIDNEY DISEASES;
RENAL DIALYSIS;
AMINOCAPROIC ACIDS;
META-ANALYSIS;
|
EID: 33646365664
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc066081 Document Type: Letter |
Times cited : (60)
|
References (5)
|